Abstract: Highlights•This study presents an explainable model for miRNA-driven drug discovery.•The introduced similarity fusion technique improves the initial representations.•The model employs subgraph estimation to mitigate the risk of “overfitting”.•Incorporating a global attention to uncover unknown miRNA–disease dependencies.
Loading